Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Endocrinology|January 20, 2010
Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTCKarin Frank-Raue, Susanne Rondot, Friedhelm Raue
Clinical Laboratory|July 4, 2007
Change in the spectrum of RET mutations diagnosed between 1994 and 2006Karin Frank-Raue, Susanne Rondot, Egbert Schulze, et al.
European Journal of Endocrinology|July 28, 2007
Efficacy of imatinib mesylate in advanced medullary thyroid carcinomaKarin Frank-Raue, Michael Fabel, Stefan Delorme, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2017
Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New MillenniumFriedhelm Raue, Henning Dralle, Andreas Machens, et al.
Clinical Endocrinology|November 25, 2011
Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancerAndreas Machens, Karin Frank-Raue, Kerstin Lorenz, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidismKarin Frank-Raue, Susanne Rondot, Wolfgang Hoeppner, et al.
Clinical Chemistry and Laboratory Medicine|July 13, 2021
Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinomaJürgen Kratzsch, Anja Willenberg, Karin Frank-Raue, et al.
Clinical Endocrinology|February 6, 2008
Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791Karin Frank-Raue, Andreas Machens, Christian Scheuba, et al.
European Journal of Endocrinology|December 6, 2012
Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new milleniumAndreas Machens, Kerstin Lorenz, Carsten Sekulla, et al.
European Journal of Endocrinology|June 10, 2011
CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrumKarin Frank-Raue, Christine Haag, Egbert Schulze, et al.
Pageof 7